Garrison Bradford & Associates’s iShares Biotechnology ETF IBB Stock Holding History

Garrison Bradford & Associates’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-30	Closed	-$3.79K	–	40
2025 Q2	$3.79K	Hold	30	–	–	﹤0.01%	58
2025 Q1	$3.84K	Buy	+30	New	+$4.07K	﹤0.01%	60
2015 Q2	–	Sell	-10,773	Closed	-$1.23M	–	95
2015 Q1	$1.23M	Hold	10,773	–	–	1.15%	20
2014 Q4	$1.09M	Buy	10,773 +4,290	+66%	+$417K	0.99%	24
2014 Q3	$591K	Sell	6,483 -897	-12%	-$78.7K	0.59%	39
2014 Q2	$632K	Buy	7,380 +1,500	+26%	+$118K	0.59%	43
2014 Q1	$463K	Buy	5,880 +1,500	+34%	+$125K	0.45%	54
2013 Q4	$332K	Hold	4,380	–	–	0.31%	62
2013 Q3	$306K	Hold	4,380	–	–	0.31%	66
2013 Q2	$254K	Buy	+4,380	New	+$253K	0.27%	73

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Garrison Bradford & Associates's IBB Position: Q3 2025 in Review

Garrison Bradford & Associates sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 30 shares — an estimated $3.79K sold.

Garrison Bradford & Associates first reported a position in IBB in Q2 2013 and held it in 10 quarters. The position peaked at $1.23M in Q1 2015. 804 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

Garrison Bradford & Associates reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
Garrison Bradford & Associates sold 30 iShares Biotechnology ETF shares in Q3 2025, an estimated $3.79K.
Garrison Bradford & Associates first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 10 quarters.
Garrison Bradford & Associates's iShares Biotechnology ETF position peaked at $1.23M in Q1 2015.
804 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Garrison Bradford & Associates's 13F filing for Q3 2025, filed 4 Nov 2025.